BioSpace News Archive

Curebase, a company committed to democratizing access to clinical studies, and Portamedic, which provides mobile examination and mobile phlebotomy services in all 50 states and Puerto Rico, have announced an ongoing partnership in which Portamedic will collect blood samples and other tests from participating decentralized clinical trial patients’ homes throughout the U.S.

Ichnos Sciences Inc., a clinical-stage global biotechnology company developing innovative multispecific antibodies for oncology, today announced that its president and chief executive officer, Cyril Konto, M.D., will present at the 2022 Jefferies Healthcare Conference in New York on Friday, June 10 at 10:00 AM Eastern Time.

June 9 discussion will focus on eli-cel for the treatment of early active cerebral adrenoleukodystrophy in patients without a matched sibling donor and overall safety of lentiviral vector (LVV) gene therapy.

Okami Medical Inc., today announced U.S. Food and Drug Administration (FDA) 510(k) clearance of the LOBO-7 and LOBO-9 Vascular Occluders, the latest addition to the company’s LOBO® Vascular Occlusion System.

The latest market analysis report published by Reports and Data, titled ‘Global Dry Eye Drugs Market – Forecast to 2028,’ thoroughly examines the Dry Eye Drugs industry to provide essential data & information for the targeted readers. The report consists of quantitative and qualitative research on the market performed by our market experts.

PineTree Therapeutics, Inc., an emerging leader in pioneering the development of disruptive therapies in Oncology, Immuno-oncology and other diseases, announced that the company has raised $23.5 Million for Series A1 funding.

Prapela, Inc. has submitted its unique bassinet pad for FDA clearance as a complementary treatment for newborns suffering from opioid withdrawal.

SYNAPS Dx (SDx), a privately held company focused on the research, development and commercialization of diagnostics for neurological disorders and conditions, including Alzheimer’s disease (AD), is pleased to acknowledge Alzheimer’s & Brain Awareness Month in June as an opportunity to raise awareness about brain disorders including AD and other dementias as a major public health issue.

A new study published in the peer-reviewed journal Translational Psychiatry finds the Visbiome® high-potency probiotic (containing the De Simone Formulation) may lessen symptoms of depression in patients with depressive disorder.

The latest market analysis report published by Reports and Data, titled ‘Global Tangential Flow Filtration Market – Forecast to 2028,’ thoroughly examines the Tangential Flow Filtration industry to provide essential data & information for the targeted readers.